deployed to eradicate tumor masses through targeted electrical disruption of malignant cell membranes.
Dr. Jennifer Munson, director of the Fralin Biomedical Research Institute Cancer Research Center, said, “Sub-ablative H-FIRE doesn’t eliminate the tumor outright, but it appears to change the rules of engagement. We’re seeing signals that may direct immune cells more effectively to the tumor site through lymphatic pathways.” #Trump100Days #AbuDhabiStablecoin #XRPETFs #BinanceAlphaAlert $BTC